Español
Nederlands
Italiano
Deutsch
Français
Português
May 15, 2025 is the date chosen by AbbVie for the payment of dividends, which will be 1,64 dollars per share.
Remember, investors in AbbVie (ABBV): April 14, 2025 is your last chance to buy and qualify for dividends, keeping in mind that the Record Date is April 15, 2025, when your ownership is verified.
The dividend from AbbVie, 1.64 dollars, was credited on February 14, 2025, following the ex-dividend on January 15, 2025.
As almost all North American companies do, AbbVie divides the annual dividend payment into four parts, depositing it quarterly in February, May, August and November.
However, its payout is approximately 80% and the dividend yield is around 4%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio AbbVie Dividends
Dividend calendar of AbbVie
These are the most important events of the AbbVie calendar in 2025:
| Event | Day |
|---|---|
| Last trading date | April 14, 2025 |
| Ex-Dividend (Ex-Date) | April 15, 2025 |
| Record date | April 15, 2025 |
| Date of payment | May 15, 2025 |
Dividend history of AbbVie
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2025 | 01/15/2025 | 1.64 $ | 1.64 $ |
| 2024 | 10/15/2024 07/15/2024 04/12/2024 01/12/2024 | 1.55 $ 1.55 $ 1.55 $ 1.55 $ | 6.2 $ |
| 2023 | 10/12/2023 07/13/2023 04/13/2023 01/12/2023 | 1.48 $ 1.48 $ 1.48 $ 1.48 $ | 5.92 $ |
| 2022 | 10/13/2022 07/14/2022 04/13/2022 01/13/2022 | 1.41 $ 1.41 $ 1.41 $ 1.41 $ | 5.64 $ |
| 2021 | 10/14/2021 07/14/2021 04/14/2021 01/14/2021 | 1.3 $ 1.3 $ 1.3 $ 1.3 $ | 5.2 $ |
| 2020 | 10/14/2020 07/14/2020 04/14/2020 01/14/2020 | 1.18 $ 1.18 $ 1.18 $ 1.18 $ | 4.72 $ |
| 2019 | 10/11/2019 07/12/2019 04/12/2019 01/14/2019 | 1.07 $ 1.07 $ 1.07 $ 1.07 $ | 4.28 $ |
| 2018 | 10/12/2018 07/12/2018 04/12/2018 01/11/2018 | 0.96 $ 0.96 $ 0.96 $ 0.71 $ | 3.59 $ |
| 2017 | 10/12/2017 07/12/2017 04/11/2017 01/11/2017 | 0.64 $ 0.64 $ 0.64 $ 0.64 $ | 2.56 $ |
| 2016 | 10/12/2016 07/13/2016 04/13/2016 01/13/2016 | 0.57 $ 0.57 $ 0.57 $ 0.57 $ | 2.28 $ |
| 2015 | 10/13/2015 07/13/2015 04/13/2015 01/13/2015 | 0.51 $ 0.51 $ 0.51 $ 0.49 $ | 2.02 $ |
| 2014 | 10/10/2014 07/11/2014 04/11/2014 01/13/2014 | 0.42 $ 0.42 $ 0.42 $ 0.4 $ | 1.66 $ |
| 2013 | 10/10/2013 07/11/2013 04/11/2013 01/11/2013 | 0.4 $ 0.4 $ 0.4 $ 0.4 $ | 1.6 $ |
Information about AbbVie
AbbVie is a company involved in the pharmaceutical industry, designing, manufacturing and marketing drugs and solutions for the treatment of a wide variety of diseases.
It was founded from the fragmentation of Abbot Laboratories in 2013, establishing its headquarters in Illinois, USA, has sales in more than 175 countries, with subsidiaries in Germany, Bermuda and The Bahamas.
Its products cover the treatment of more than 60 pathologies, including immunology, oncology, neuroscience, ophthalmology, esthetics and virology, with research and development operations in 20 countries and more than 50,000 employees distributed among its various factories.
Its operations emphasize research and personalization of therapies, tailored to the needs of each patient, investing in technologies such as precision medicine, genetics, data convergence and genomics.
Frequently asked questions about AbbVie dividends
AbbVie pays dividends on a Trimestral basis.
AbbVie is listed on the New York Stock Exchange and is part of the Nyse.
AbbVie has the Ticker or stock code ABBV.
The CEO of AbbVie in 2025 is Mr. Richard A. Gonzalez.
AbbVie has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.